Trump Admin Fast-Tracks Psychedelic Therapies for Serious Mental Illness
TL;DR Summary
Trump signs an executive order to accelerate psychedelic therapies for serious mental illness, directing FDA to use national priority vouchers for breakthrough psychedelic drugs, create pathways to access investigational psychedelics under the Right to Try Act, and invest $50 million via ARPA-H to boost research; the plan calls for VA and private‑sector collaboration to expand trials and aims to help veterans and reduce suicide, building on prior Right to Try and drug research reforms.
- Fact Sheet: President Donald J. Trump is Accelerating Medical Treatments for Serious Mental Illness The White House (.gov)
- Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’ CNN
- Trump signs order to speed review of psychedelics, including the controversial drug ibogaine Pittsburgh Post-Gazette
- Trump Signs Executive Order to Loosen Restrictions on Psychedelic Drugs The New York Times
- Trump orders more access to psychedelics like LSD, psilocybin, ibogaine The Washington Post
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
89%
702 → 74 words
Want the full story? Read the original article
Read on The White House (.gov)